Case Report
Persistent COVID-19 Pneumonia and Failure to Develop Anti-SARS-CoV-2 Antibodies During Rituximab Maintenance Therapy for Follicular Lymphoma

https://doi.org/10.1016/j.clml.2020.08.017Get rights and content

Keywords

Atypical presentation
CHOP
Coronavirus
Hematological malignancy
Obinutuzumab

Cited by (0)

View Abstract